Page 46 - Read Online

88. Zhou L, Miranda-Saksena M, Saksena NK. Viruses and disease. Neurosci Lett 2006;391:147-9.
neurodegeneration. Virol J 2013;10:172. 101. Jin J-J, Kim H-D, Maxwell JA, Li L, Fukuchi K. Toll-like receptor
89. Wu WY, Kang KH, Chen SL, Chiu SY, Yen AM, Fann JC, Su CW, Liu 4-dependent upregulation of cytokines in a transgenic mouse model
HC, Lee CZ, Fu WM, Chen HH, Liou HH. Hepatitis C virus infection: of Alzheimer’s disease. J Neuroinflammation 2008;5:3006-19.
a risk factor for Parkinson’s disease. J Viral Hepat 2015;22:784-91. 102. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of
90. Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, toll-like receptor signalling in Abeta uptake and clearance. Brain
Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C. Does hiv 2006;129:3006-19.
infection alter parkinson’s disease? J Acquir Immune Defic Syndr 103. Herber DL, Roth LM, Wilson D, Wilson N, Mason JE, Morgan
2015;70:129-36. D, Gordon MN. Time-dependent reduction in Aβ levels after
91. Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM. intracranial LPS administration in APP transgenic mice. Exp Neurol
Hypothesis: a role for EBV-induced molecular mimicry in Parkinson’s 2004;190:245-53.
disease. Parkinsonism Relat Disord 2014;20:685-94. 104. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP,
92. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning Stenzel-Poore MP. Endotoxin preconditioning prevents cellular
CJ, Häcker H, Wagner H. Endocytosed HSP60s use toll-like inflammatory response during ischemic neuroprotection in mice.
receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 Stroke 2004;35:2576-81.
receptor signaling pathway in innate immune cells. J Biol Chem 105. De Paola M, Mariani A, Bigini P, Peviani M, Ferrara G, Molteni M,
2001;276:31332-9. Gemma S, Veglianese P, Castellaneta V, Boldrin V, Rossetti C,
93. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson Chiabrando C, Forloni G, Mennini T, Fanelli R. Neuroprotective effects
MA, Calderwood SK. Novel signal transduction pathway utilized by of Toll-like receptor 4 antagonism in spinal cord cultures and in a mouse
extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J model of motor neuron degeneration. Mol Med 2012;18:971-81.
Biol Chem 2002;277:15028-34. 106. Zeng KW, Zhang T, Fu H, Liu GX, Wang XM. Schisandrin B
94. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, exerts anti-neuroinflammatory activity by inhibiting the Toll-like
Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, receptor 4-dependent MyD88/IKK/NF-kappaB signaling pathway
Kwak LW. Toll-like receptor 4-dependent activation of dendritic in lipopolysaccharide-induced microglia. Eur J Pharmacol
cells by beta-defensin 2. Science 2002;298:1025-9. 2012;692:29-37.
95. Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, 107. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke:
Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, Dodel role of inflammatory cells. J Leukoc Biol 2010;87:779-89.
RC, Lu L, Hirsch EC, Hunot S, Hartmann A. Toll like receptor 4 108. Ohto U, Tanji H, Shimizu T. Structure and function of toll-like
mediates cell death in a mouse MPTP model of Parkinson disease. receptor 8. Microbes Infect 2014;16:273-82.
Sci Rep 2013;3:1393. 109. Brea D, Sobrino T, Rodríguez-Yáñez M, Ramos-Cabrer P, Agulla
96. Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W, Wenning GK. J, Rodríguez-González R, Campos F, Blanco M, Castillo J. Toll-
Toll-like receptor 4 promotes alpha-synuclein clearance and survival like receptors 7 and 8 expression is associated with poor outcome
of nigral dopaminergic neurons. Am J Pathol 2011;179:954-63. and greater inflammatory response in acute ischemic stroke. Clin
97. Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Immunol 2011;139:193-8.
Lee VM. Neuroinflammation and oxidation/nitration of alpha- 110. Tang SC, Yeh SJ, Li YI, Wang YC, Baik SH, Santro T, Widiapradja A,
synuclein linked to dopaminergic neurodegeneration. J Neurosci Manzanero S, Sobey CG, Jo DG, Arumugam TV, Jeng JS. Evidence
2008;28:7687-98. for a detrimental role of TLR8 in ischemic stroke. Exp Neurol
98. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg 2013;250:341-347.
PA, Volpe JJ, Vartanian T. Activation of innate immunity in the CNS 111. Piersanti S, Astrologo L, Licursi V, Costa R, Roncaglia E, Gennetier
triggers neurodegeneration through a Toll-like receptor 4-dependent A, Ibanes S, Chillon M, Negri R, Tagliafico E, Kremer EJ, Saggio
pathway. Proc Natl Acad Sci U S A 2003;100:8514-9. I. Differentiated neuroprogenitor cells incubated with human or
99. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode canine adenovirus, or lentiviral vectors have distinct transcriptome
B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K. Role profiles. PLoS One 2013;8:e69808.
of the toll-like receptor 4 in neuroinflammation in Alzheimer’s 112. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism.
disease. Cell Physiol Biochem 2007;20:947-956. Biochim Biophys Acta (BBA)-Molecular Basis Dis 2009;1792:714-21.
100. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen 113. Diogenes A, Ferraz CC, Akopian AN, Henry MA, Hargreaves KM. LPS
E, Reino M, Geroldi D. Effect of the functional toll-like receptor 4 sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons.
Asp299Gly polymorphism on susceptibility to late-onset Alzheimer’s J Dent Res 2011;90:759-64.

Neuroimmunol Neuroinflammation | Volume 3 | Issue 2 | February 15, 2016 37